Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

SJ, I’m just riding along waiting to see

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Gpheart2016 Member Profile
 
Followed By 1
Posts 267
Boards Moderated 0
Alias Born 10/19/16
160x600 placeholder
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock GlobeNewswire Inc. - 2/18/2021 4:01:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/17/2021 5:10:29 PM
Bio-Path slips 8% on capital raise Seeking Alpha - 2/16/2021 7:41:11 AM
Bio-Path Holdings, Inc. Announces Pricing of $13.0 Million Public Offering of Common Stock GlobeNewswire Inc. - 2/16/2021 7:15:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/16/2021 7:02:13 AM
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. - 2/13/2021 7:00:00 AM
Bio-Path stock soars on U.S. patent grant Seeking Alpha - 2/10/2021 10:48:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/10/2021 9:18:21 AM
APHA, TLRY, SNDL and OGI among premarket gainers Seeking Alpha - 2/10/2021 8:23:26 AM
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology GlobeNewswire Inc. - 2/10/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2020 4:18:59 PM
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002 GlobeNewswire Inc. - 11/19/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 7:12:10 AM
Bio-Path Holdings Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/13/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 4:12:44 PM
Bio-Path Holdings to Announce Third Quarter 2020 Financial Results on November 13, 2020 GlobeNewswire Inc. - 11/6/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/5/2020 4:25:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/5/2020 4:20:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2020 4:31:22 PM
Bio-Path Receives Notice of Allowance for Strategic Patent for Prexigebersen in Combination with Front Line Cytidine Analogue... GlobeNewswire Inc. - 10/22/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2020 4:17:35 PM
Bio-Path Holdings to Present at the H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Bio-Path Holdings Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/14/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2020 4:31:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 4:12:37 PM
Gpheart2016   Friday, 07/05/19 10:45:57 AM
Re: SJSTOCKSHARK post# 6163
Post # of 6320 
SJ, I’m just riding along waiting to see what happens. But it seems that short sellers look for a low float stock as it is easier to manipulate. And I agree that the higher price makes it an easier target. JMO

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences